AHL
HALO icon

Abel Hall LLC’s Halozyme HALO Stock Holding History

Abel Hall LLC’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
3,453
+223
+7% +$15.2K 0.05% 539
2026
Q1 		$209K Buy
3,230
+14
+0.4% +$987 0.04% 603
2025
Q4 		$216K Buy
3,216
+129
+4% +$8.68K 0.05% 504
2025
Q3 		$226K Buy
+3,087
New +$205K 0.09% 240
2025
Q2 		– Sell
-3,250
Closed -$207K – 304
2025
Q1 		$207K Buy
+3,250
New +$189K 0.13% 160

Other funds holding HALO

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Abel Hall LLC's HALO Position: Q2 2026 in Review

Abel Hall LLC increased its Halozyme (HALO) stake by 6.9% in Q2 2026, buying an estimated $15.2K and bringing the position to 3,453 shares worth $270K. The position accounts for 0.05% of the portfolio, ranked #539.

Abel Hall LLC first reported a position in HALO in Q1 2025 and has held it in 5 quarters since. 207 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Abel Hall LLC held 3,453 shares of Halozyme worth $270K as of Q2 2026.
  • Abel Hall LLC bought 223 Halozyme shares in Q2 2026, an estimated $15.2K.
  • Halozyme made up 0.05% of Abel Hall LLC's portfolio in Q2 2026, its #539 holding.
  • Abel Hall LLC first reported a position in Halozyme in Q1 2025 and has held it in 5 quarters since.
  • 207 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.